Clinical Trial Update: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy [NA]

View source ↗

Summary

Clinical trial update reporting completion of a prognostic study of angiogenesis and coagulability markers in patients with monoclonal gammopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy
• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Snippet

Sponsor: Rennes University Hospital | Conditions: Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Signification | NA | Status: COMPLETED